FluInsure intranasal vaccine: IDBE will begin this month a double-blind, placebo-controlled Phase II trial in Canada of its FluInsure intranasal vaccine to prev

ID Biomedical Corp. (IDBE; TSE:IDB), Vancouver, B.C.
Product:

Read the full 84 word article

How to gain access

Continue reading with a
two-week free trial.